Home Pharmaceutical Management Prophylaxis in Migraine Management

Prophylaxis in Migraine Management

by admin
Published on: January 2009
Journal of Young Pharmacists, 2009; 1(1):86-89
Pharmaceutical Management | doi:10.4103/0975-1483.51877
Authors:

Sonal Sekhar M, Aneesh TP, Sathianarayanan S, JinyVarghese K, Vasudevan DT, Revikumar KG

Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham University, AIMS Healthcare Campus, AIMS Ponekkara (P.O), Kochi, Kerala – 682 041, India

Address for correspondence: Mr. Sonal Sekhar M.; E-mail: [email protected]

Abstract:

A migraine is the most common cause of severe, recurring headache. With the recent advances in our understanding of migraine, it can be effectively treated and even prevented. Prophylactic treatment of migraines is indicated when patients have three or more severe migraine attacks a month that interfere with quality of life or when attacks are prolonged and symptomatic medication used alone is not satisfactory. The major objective of migraine prophylactic therapy is optimizing the patient’s ability to function normally by reducing the frequency, duration, and intensity of attacks. The major migraine preventive therapies include β-blockers, calcium-channel blockers, and tricyclic medications. Preventive treatment should be tailored to individual patient needs. This requires that patient and healthcare professionals understand the rationale and participate actively in decisions regarding therapeutic intervention.

Key words: Migraine, migraine management, prophylaxis.